Brief: Lansen Pharmaceutical updates on share reduction plan of Zhejiang Starry Pharmaceutical
Sept 19 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* Lansen HK notified Starry about second share reduction in
relation to its holding in Starry shares
* As at sept 19, Lansen HK and Full Keen disposed an
aggregate of 4.2 mln Starry shares
* Not more than 5.5 mln starry shares to be disposed,
representing not more than 4.583 pct of total number of issued
shares in starry
Source text for Eikon: ID:nHKS7fyRLv
Further company coverage: 0503.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year